经颈动脉与经锁骨下动脉/腋窝入路经导管主动脉瓣置换术（TAVR）：结局分析。
Transcarotid Versus Transaxillary/Subclavian Transcatheter Aortic Valve Replacement (TAVR): Analysis of Outcomes.
机构信息
Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ.
Department of Cardiovascular Surgery, Mayo Clinic, Phoenix, AZ.
出版信息
J Cardiothorac Vasc Anesth. 2022 Jun;36(6):1771-1776. doi: 10.1053/j.jvca.2021.04.035. Epub 2021 Apr 28.
Transcatheter aortic valve replacement (TAVR) has revolutionized the percutaneous management of valvular heart disease and has evolved to progressively minimalist techniques over the past decade. This review discusses the impact of minimalist TAVR, explores the alternative approaches when transfemoral (TF) TAVR is not possible, and analyzes the current outcomes of transcarotid (TC) versus transaxillary/subclavian (TAx) TAVR, which are the two leading nonfemoral (NF) approaches emerging as the preferred alternatives to TF TAVR.
经导管主动脉瓣置换术（TAVR）彻底改变了瓣膜性心脏病的经皮治疗方式，并在过去十年中发展为越来越微创的技术。本文讨论了微创 TAVR 的影响，探讨了经股动脉（TF）TAVR 不可行时的替代方法，并分析了经颈动脉（TC）与经腋动脉/锁骨下动脉（TAx）TAVR 的当前结果，这两种非股动脉（NF）方法是 TF TAVR 的首选替代方法。
Zotero 插件